Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06562439 · ClinicalTrials.gov registry record · NA

Testing the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) Intervention

A NA study, sponsored by Washington University School of Medicine.

Not yet
Registry status
NA
Development phase
50
Enrollment target

NCT06562439 is a NA study that has not yet begun recruiting, run by Washington University School of Medicine. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06562439, a NA study, has not yet begun recruiting, sponsored by Washington University School of Medicine.

NOT YET RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

Sickle cell disease affects 100,000 people and 2,000 newborns each year; 50% of these children have a developmental deficit (\>2 SD) before the age of 3. Early identification of developmental deficit supports timely intervention, but children with sickle cell disease are grossly underdiagnosed and undertreated. The goal of the proposed study is to determine the incidence and severity of developmental deficit at 9, 18 and 30 months of age among children with sickle cell disease and test a 12-month, home-based caregiver intervention with this disproportionately affected population.

Interventions

  • BEHAVIORAL Sickle Cell Collaboration for Child Development

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-01-01
Est. Completion 2028-07-31
Phase NA

What the Registry Record Tells You About NCT06562439

The ClinicalTrials.gov registry entry for NCT06562439 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Sickle Cell Collaboration for Child Development is the first listed.

NCT06562439 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06562439 about?

NCT06562439 is a clinical study titled "Testing the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) Intervention". Sickle cell disease affects 100,000 people and 2,000 newborns each year; 50% of these children have a developmental deficit (\>2 SD) before the age of 3. Early identification of developmental deficit supports timely intervention, but children with sickle cell disease are grossly underdiagnosed and u...

What is the current status of trial NCT06562439?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-01-01. Estimated completion is 2028-07-31.

What interventions are being tested in trial NCT06562439?

The interventions under investigation include: Sickle Cell Collaboration for Child Development (BEHAVIORAL).

Who is sponsoring clinical trial NCT06562439?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.